All manuscripts
Literature

Proven Process

Share
2 pages Proven Process

Overview

This is our proven process illustrating how ScaleReady works in a true partnership with your T and NK cell therapy program to enable the successful commercialization of your drug. This is a linear left-to-right, as well as a holistic view, of how at every stage, we look to simplify, streamline, and scale by offering expertise and support for your cell therapy program. Through our proven process, we deliver practical and viable solutions by providing the most simple, scalable, and versatile manufacturing products. Our process is proven, as our products are represented in approved CAR-T drugs around the globe.

What this paper found

ScaleReady sets out a staged partnership model for moving T cell and NK cell therapy programmes from discovery through to commercial manufacture, and reports no experiments, patients or laboratory measurements. The stages named are discovery, product testing, proof of concept, custom protocols, data review, process optimisation, process scaling, scalable results and commercialisation. The company states that testing done at minimum scale is fully translational to maximum scale, and that repeatability, consistency and predictability of outcomes are preserved without sacrificing quality or cost. Technical account managers and field application specialists arrange samples and in-person demonstrations, and the document claims the company's products are represented in approved CAR-T drugs. No G-Rex® model, culture protocol or quantitative result is given anywhere.

Full citation

The ScaleReady Proven Process: Our Partnership with T & NK Cell Therapy Programs. ScaleReady, LLC. 2025.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →